DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

15 Oct 2012

Topotargets Belinostat får Orphan Drug-status i EU

Europa-Kommissionen har tildelt Topotarget A/S Orphan Drug-status for belinostat, selskabets innovative histon deacetylase (HDAC)-hæmmer til behandling af perifert T-celle lymfekræft (PTCL). PTCL er en sjælden form for non-Hodgkins lymfom.

Belinostat fik i september 2009 tildelt Orphan Drug-status i USA af de amerikanske sundhedsmyndigheder (FDA) for behandlingen af PTCL.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2012 Danskbiotek. All rights reserved.